Coagulation parameters abnormalities and their relation to clinical outcomes in hospitalized and severe COVID-19

Hend M Esmaeel1, Heba A Ahmed2, Mahmoud I Elbadry3

  • 1Department of Chest Disease and Tuberculosis, Faculty of Medicine, Sohag University, Sohag, 82524, Egypt. hendomr@gmail.com.

Scientific Reports
|August 1, 2022
PubMed

Insights

Coagulation abnormalities, including D-dimer and Anti-Thrombin III, effectively predict COVID-19 severity and poor outcomes. Monitoring these markers aids in early risk assessment and patient management.

Area of Science:

  • Hematology
  • Virology
  • Clinical Medicine

Background:

  • Growing attention on coagulation parameter abnormalities in predicting COVID-19 severity.
  • Coagulation disorders are increasingly recognized as a significant factor in COVID-19 prognosis.

Purpose of the Study:

  • To investigate the predictive role of coagulation parameters (Prothrombin concentration, aPTT, D-Dimer, ATIII, fibrinogen) in COVID-19 severity.
  • To assess the relationship between coagulation, hematological, and biochemical parameters and clinical outcomes in hospitalized and severe COVID-19 patients.

Main Methods:

  • Prospective study of 267 newly diagnosed COVID-19 patients.
  • Patients categorized into hospitalized/non-hospitalized and severe/non-severe groups.
  • Clinical evaluation, measurement of coagulation, hematological, and biochemical parameters, and outcome data collection.

Main Results:

  • Hospitalized and severe COVID-19 patients were older and presented more frequently with dyspnea.
  • Significant differences in coagulation and inflammatory markers were observed between severity groups.
  • D-dimer, AT-III, and LDH demonstrated excellent independent prediction of severity risk (D-dimer: 76% sensitivity, 93% specificity at >2.0 ng/L).
  • Patients with coagulation abnormalities had significantly worse survival rates (p=0.002).

Conclusions:

  • Coagulation parameters, particularly D-dimer and AT-III, are valuable predictors of COVID-19 severity.
  • Early assessment and monitoring of coagulation status can aid in predicting COVID-19 severity and mortality risk.

Related Concept Videos

Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
30
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
40
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
56